Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk

被引:185
作者
Cummings, Steven R. [1 ,4 ]
Tice, Jeffrey A. [3 ]
Bauer, Scott [4 ,5 ]
Browner, Warren S. [1 ]
Cuzick, Jack [6 ]
Ziv, Elad [3 ]
Vogel, Victor [7 ]
Shepherd, John [2 ]
Vachon, Celine [8 ]
Smith-Bindman, Rebecca [2 ]
Kerlikowske, Karla [3 ,4 ]
机构
[1] Calif Pacific Med Ctr Res Inst, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA
[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Canc Res UK, London, England
[7] Univ Pittsburgh, Magee Womens Canc Ctr, Pittsburgh, PA USA
[8] Mayo Clin, Coll Med, Rochester, MN USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 06期
关键词
SURGICAL ADJUVANT BREAST; SERVICES-TASK-FORCE; CARCINOMA IN-SITU; RECREATIONAL PHYSICAL-ACTIVITY; HORMONE-RECEPTOR STATUS; ADULT WEIGHT CHANGE; BOWEL PROJECT P-1; MAMMOGRAPHIC DENSITY; ALCOHOL-CONSUMPTION; OVARIAN-CANCER;
D O I
10.1093/jnci/djp018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background It is uncertain whether evidence supports routinely estimating a postmenopausal woman's risk of breast cancer and intervening to reduce risk. Methods We systematically reviewed prospective studies about models and sex hormone levels to assess breast cancer risk and used meta-analysis with random effects models to summarize the predictive accuracy of breast density. We also reviewed prospective studies of the effects of exercise, weight management, healthy diet, moderate alcohol consumption, and fruit and vegetable intake on breast cancer risk, and used random effects models for a meta-analyses of tamoxifen and raloxifene for primary prevention of breast cancer. All studies reviewed were published before June 2008, and all statistical tests were two-sided. Results Risk models that are based on demographic characteristics and medical history had modest discriminatory accuracy for estimating breast cancer risk (c-statistics range = 0.58-0.63). Breast density was strongly associated with breast cancer (relative risk [RR] = 4.03, 95% confidence interval [CI] = 3.10 to 5.26, for Breast Imaging Reporting and Data System category IV vs category I; RR = 4.20, 95% CI = 3.61 to 4.89, for >75% vs <5% of dense area), and adding breast density to models improved discriminatory accuracy (c-statistics range = 0.63-0.66). Estradiol was also associated with breast cancer (RR range = 2.0-2.9, comparing the highest vs lowest quintile of estradiol, P<.01). Most studies found that exercise, weight reduction, low-fat diet, and reduced alcohol intake were associated with a decreased risk of breast cancer. Tamoxifen and raloxifene reduced the risk of estrogen receptor-positive invasive breast cancer and invasive breast cancer overall. Conclusions Evidence from this study supports screening for breast cancer risk in all postmenopausal women by use of risk factors and breast density and considering chemoprevention for those found to be at high risk. Several lifestyle changes with the potential to prevent breast cancer should be recommended regardless of risk.
引用
收藏
页码:384 / 398
页数:15
相关论文
共 105 条
  • [11] Heritability of mammographic density, a risk factor for breast cancer
    Boyd, NF
    Dite, GS
    Stone, J
    Gunasekara, A
    English, DR
    McCredie, MRE
    Giles, GG
    Tritchler, D
    Chiarelli, A
    Yaffe, MJ
    Hopper, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) : 886 - 894
  • [12] Mammographic density and the risk and detection of breast cancer
    Boyd, Norman F.
    Guo, Helen
    Martin, Lisa J.
    Sun, Limei
    Stone, Jennifer
    Fishell, Eve
    Jong, Roberta A.
    Hislop, Greg
    Chiarelli, Anna
    Minkin, Salomon
    Yaffe, Martin J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (03) : 227 - 236
  • [13] Dietary fibre and risk of breast cancer in the UK Women's Cohort Study
    Cade, Janet Elizabeth
    Burley, Victoria Jane
    Greenwood, Darren Charles
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (02) : 431 - 438
  • [14] Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
    Cauley, JA
    Norton, L
    Lippman, ME
    Eckert, S
    Krueger, KA
    Purdie, DW
    Farrerons, J
    Karasik, A
    Mellstrom, D
    Ng, KW
    Stepan, JJ
    Powles, TJ
    Morrow, M
    Costa, A
    Silfen, SL
    Walls, EL
    Schmitt, H
    Muchmore, DB
    Jordan, VC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) : 125 - 134
  • [15] Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density
    Chen, Jinbo
    Pee, David
    Ayyagari, Rajeev
    Graubard, Barry
    Schairer, Catherine
    Byrne, Celia
    Benichou, Jacques
    Gail, Mitchell H.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) : 1215 - 1226
  • [16] Predicting risk of breast cancer in postmenopausal women by hormone receptor status
    Chlebowski, Rowan T.
    Anderson, Garnet L.
    Lane, Dorothy S.
    Aragaki, Aaron K.
    Rohan, Thomas
    Yasmeen, Shagufta
    Sarto, Gloria
    Rosenberg, Carol A.
    Hubbell, F. Allan
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (22): : 1695 - 1705
  • [17] Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study
    Chlebowski, Rowan T.
    Blackburn, George L.
    Thomson, Cynthia A.
    Nixon, Daniel W.
    Shapiro, Alice
    Hoy, M. Katherine
    Goodman, Marc T.
    Giuliano, Armando E.
    Karanja, Njeri
    McAndrew, Philomena
    Hudis, Clifford
    Butler, John
    Merkel, Douglas
    Kristal, Alan
    Caan, Bette
    Michaelson, Richard
    Vinciguerra, Vincent
    Del Prete, Salvatore
    Winkler, Marion
    Hall, Rayna
    Simon, Michael
    Winters, Barbara L.
    Elashoff, Robert M.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (24): : 1767 - 1776
  • [18] American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition
    Chlebowski, RT
    Col, N
    Winer, EP
    Collyar, DE
    Cummings, SR
    Vogel, VG
    Burstein, HJ
    Eisen, A
    Lipkus, I
    Pfister, DG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3328 - 3343
  • [19] THE CALCULATION OF BREAST-CANCER RISK FOR WOMEN WITH A FIRST DEGREE FAMILY HISTORY OF OVARIAN-CANCER
    CLAUS, EB
    RISCH, N
    THOMPSON, WD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (02) : 115 - 120
  • [20] CLAUS EB, 1991, AM J HUM GENET, V48, P232